Company Valuation: Genpharmasec Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 2,808 2,218 1,523 861 1,235 1,009
Change - -21.03% -31.34% -43.45% 43.41% -18.31%
Enterprise Value (EV) 1 2,760 2,074 1,463 855.3 1,056 999.3
Change - -24.83% -29.46% -41.55% 23.46% -5.36%
P/E 648x 173x -550x 77.8x -545x 94.5x
PBR 14.8x 10.7x 9.91x 5.62x 1.85x 1.61x
PEG - 1x 5x -0x 5x -0x
Capitalization / Revenue 17x 10.4x 5.57x 3.37x 4.06x 2.99x
EV / Revenue 16.7x 9.74x 5.36x 3.35x 3.47x 2.96x
EV / EBITDA 422x 174x -281x 319x 5,126x -249x
EV / EBIT 426x 176x -273x 344x 27,075x -134x
EV / FCF -548x 282x -33.1x -19.6x -36.2x -110x
FCF Yield -0.18% 0.35% -3.02% -5.1% -2.76% -0.91%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 0.02 0.0464 -0.01 0.04 -0.004091 0.02
Distribution rate - - - - - -
Net sales 1 165 213.1 273.2 255.2 304.1 337.2
EBITDA 1 6.534 11.94 -5.213 2.681 0.206 -4.021
EBIT 1 6.485 11.82 -5.355 2.484 0.039 -7.472
Net income 1 10.09 12.57 -2.093 11.25 -1.257 12.31
Net Debt 1 -48.63 -143.2 -59.41 -5.736 -178.9 -9.403
Reference price 2 12.950 8.010 5.500 3.110 2.230 1.890
Nbr of stocks (in thousands) 216,860 276,860 276,860 276,860 553,720 533,720
Announcement Date 28/11/20 06/09/21 06/09/22 01/09/23 01/07/24 05/09/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 6.03M
30.24x4.11x15.98x2.44% 183B
19.42x3.39x11.94x3.47% 110B
17.37x0.19x12.26x0.76% 60.75B
30.04x7.29x19x1.33% 50.01B
36.03x3.22x10.97x2.37% 45.59B
37.5x1.37x12.06x0.21% 33.08B
30.28x5.41x17.22x-.--% 28.76B
39.6x6.94x24.84x0.27% 23.9B
24.62x3.73x13.08x1.13% 22.53B
Average 29.45x 3.96x 15.26x 1.33% 55.71B
Weighted average by Cap. 27.77x 3.77x 14.73x 1.95%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. ADIRASA Stock
  4. Valuation Genpharmasec Limited